Table 3.
HDL-Sz | HDL-C/P ratio | |||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Unadjusted | 1.36 (1.16–1.58) | < 0.001 | 1.06 (1.03–1.09) | < 0.001 |
Multivariable adjustment | ||||
Model 1 | 1.21 (1.01–1.47)* | 0.041 | 1.04 (1.01–1.07)* | 0.008 |
Model 2 | 1.22 (1.01–1.47)* | 0.041 | 1.04 (1.01–1.07)* | 0.008 |
Hazard ratios for HDL-Sz reflect 1 SD change in a given measure.
Model 1 Adjusted for age, sex, BMI, diabetes, arterial hypertension, vasculopathy, ischemic etiology, NYHA functional class III-IV, eGFR, Hemoglobin, NT-ProBNP, LDL-P and treatment with ACEi/ARB, Betablockers, statins and ICD.
Model 2 Adjusted for Model 1 plus glycoprotein (Gly)-A, Gly-B and Gly-F.
*Other independent predictors of the outcomes in these models besides HDL-Sz or HDL-C/P were age, ischaemic etiology and NT-proBNP.